Company planning a demerger to unlock shareholders value ,as it is the only pharma company with lowest PE which is 10 , though company enjoys good revenue
Also keep an eye on 20 EMA
Can be bought for short time period
Also keep an eye on 20 EMA
Can be bought for short time period
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。